A

Atea Pharmaceuticals
D

AVIR

5.18500
USD
-0.08
(-1.52%)
مغلق
حجم التداول
17,477
الربح لكل سهم
0
العائد الربحي
-
P/E
-2
حجم السوق
415,861,364
أصول ذات صلة المقالات
المزيد

العنوان: Atea Pharmaceuticals

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.